Preparing your regulatory team for the new SENDIG-GeneTox requirements.
Read the latest from our Sensible SEND blog.
Read the latest blog from Marc Ellison, Director, SEND Solutions, Instem.
Watch this 40-minute presentation to learn more about Weight of Evidence approaches and the use of SEND datasets
Meet Marc Ellison, Director, SEND Solutions, Instem.
The ICH S1B guidance is making significant ripples across our industry, potentially saving years of effort in the development of a new drug, and SEND can play its part in enabling this.
